Fabric Genomics said today it has partnered with data management company ITTM (Information Technology for Translational Medicine) to provide secure genomic data hosting capabilities for European customers, through a collaboration whose value was not disclosed.
The companies said they will be able to deliver top-tier genomic technology and patient privacy solutions to clinical labs, pharmaceutical companies, and genome projects, by combining Fabric Genomics’ analysis tools with ITTM’s secure hosting and infrastructure solutions.
Fabric Genomics’ platform is a scalable end-to-end genomic data analysis solution that offers secondary analysis, tertiary analysis, and clinical reporting. The company says its secondary analysis tools are designed to process genomic data with high computing efficiency, fast turnaround times, exceptional accuracy, and 100% consistency.
According to Fabric, its Biograph technology enables accurate detection of structural variants and provides population-scale data mining capabilities—while its software can process FASTQ, BAM or VCF files, providing alignment, variant calling, guideline-driven variant classification, variant interpretation, and clinical reporting for hereditary diseases and oncology.
Fabric Genomics already has European customers that include Genomics England’s 100,000 Genomes Project, which aims to sequence 100,000 whole genomes from NHS patients and family members affected by rare genetic diseases, as well as common cancers. Fabric’s Opal Clinical platform has delivered more than 500 clinical reports for the 100,000 Genome Project, with the intent of improving therapeutic treatments through genomic medicine.
Opal Clinical, Fabric’s tertiary analysis tool for interpretation, classification, and annotation, uses proprietary VAAST and Phevor algorithms designed to help identify casual mutation(s) in high-complexity cases, such as pediatric diagnostic odysseys and country sequencing projects.
Other Fabric Genomics customers include LabCorp, Rady Children’s Institute for Genomic Medicine, and Vanderbilt University Medical Center, a clinical site for the NIH’s Undiagnosed Disease Network (UDN).
“More and more clinicians are sequencing patient data for rare diseases and cancer, and there is a need to quickly and accurately interpret this data,” Andreas Kremer, Ph.D., ITTM co-founder and general manager, said in a statement. “In some EU countries, regulations prohibit the transfer of personal data across borders, so we are thrilled to provide optimal hosting services to those customers who do not have their own servers.”
ITTM is a spin-off company of the Luxembourg Centre for Systems Biomedicine (LCSB) of The University of Luxembourg that provides data integration and knowledge management solutions and services to all areas of biomedical research. ITTM says it focuses on providing quality, contextual data in translational medicine studies and clinical trials, where heterogeneous data need to be curated, linked and integrated.